Director at ClearPoint Neuro (CLPT) receives 12,820 restricted stock units

(Neutral)

Form Type

Rhea-AI Filing Summary

Richards Timothy T. reported acquisition or exercise transactions in this Form 4 filing.

ClearPoint Neuro, Inc. director Timothy T. Richards received a grant of 12,820 restricted stock units. Each unit represents a right to receive one share of CLPT common stock and will vest on the earlier of the first anniversary of the grant date or the day immediately before the 2027 annual meeting of stockholders.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Richards Timothy T.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	12,820	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 12,820 shares (Direct)

Footnotes (2)

F1. Each restricted stock unit represents a contingent right to receive one share of CLPT common stock.
F2. The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2027 annual meeting of stockholders.

Key Figures

RSUs granted: 12,820 units Exercise/conversion price: $0.00 per unit Units after transaction: 12,820 units +2 more

5 metrics

RSUs granted 12,820 units Restricted stock unit award to director on May 21, 2026

Exercise/conversion price $0.00 per unit Restricted stock units granted at no cash exercise price

Units after transaction 12,820 units Total restricted stock units from this grant following the transaction

Vesting trigger 1 First anniversary of grant date Time-based vesting condition for RSUs

Vesting trigger 2 Day before 2027 annual meeting Alternative vesting date linked to 2027 stockholders meeting

Key Terms

Restricted Stock Units, contingent right, vest, annual meeting of stockholders

4 terms

Restricted Stock Units financial

"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock."

vest financial

"The restricted stock units vest on the earlier of the first anniversary of the grant date, or the day immediately preceding the Company's 2027 annual meeting of stockholders."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

annual meeting of stockholders financial

"The restricted stock units vest on the earlier of the first anniversary of the grant date, or the day immediately preceding the Company's 2027 annual meeting of stockholders."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 05/26/2026 - 04:30 PM

FAQ

What insider transaction did ClearPoint Neuro (CLPT) report for Timothy T. Richards?

ClearPoint Neuro reported that director Timothy T. Richards received 12,820 restricted stock units. These awards are a form of equity compensation and give him the right to receive an equal number of CLPT common shares if the vesting conditions are met.

How many restricted stock units did Timothy T. Richards receive from ClearPoint Neuro (CLPT)?

Timothy T. Richards was granted 12,820 restricted stock units. After this award, his reported derivative holdings from this grant total 12,820 units, each corresponding to one share of ClearPoint Neuro common stock when the units vest under the specified schedule.

What does each restricted stock unit granted by ClearPoint Neuro (CLPT) represent?

Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro common stock. The units do not deliver shares immediately; instead, shares are issued only when the vesting requirements described in the grant terms are satisfied in the future.

When do the ClearPoint Neuro (CLPT) restricted stock units granted to Timothy T. Richards vest?

The restricted stock units vest on the earlier of the first anniversary of the grant date or the day immediately preceding ClearPoint Neuro’s 2027 annual meeting of stockholders. This dual condition ties vesting to both time-based service and the company’s regular meeting cycle.

Is the ClearPoint Neuro (CLPT) Form 4 transaction a market purchase or sale?

The Form 4 reflects a grant of restricted stock units, not a market trade. The transaction code is “A,” indicating a grant or award acquisition, so no open-market buying or selling of ClearPoint Neuro common stock occurred in this specific insider filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Richards Timothy T.

(Last)

(First)

(Middle)

C/O CLEARPOINT NEURO, INC.

120 S. SIERRA AVE., SUITE 100

(Street)

SOLANA BEACH

CALIFORNIA

92075

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ClearPoint Neuro, Inc. [ CLPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	05/21/2026		A		12,820		⁽²⁾	⁽²⁾	Common Stock	12,820	$0	12,820	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of CLPT common stock.

2. The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2027 annual meeting of stockholders.

	/s/ Danilo D'Alessandro, by Power of Attorney for Timothy T. Richards	05/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR